COMMUNIQUÉS West-GlobeNewswire

DeepView® System Highlighted at the 2026 British Burn Association Annual Conference
25/06/2026
Dr. Jeffrey Carter Awarded BBA Oral Presentation 1st Prize for his Paper on the Use of Multi-Spectral Imaging with Artificial Intelligence for Burn Wounds DALLAS, June 25, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. ( [...]
Arrakis Therapeutics Announces CEO Transition with Mark DeLong Appointed as New CEO
25/06/2026
— Mark DeLong to lead Arrakis as it becomes a clinical-stage company, advancing its lead oral RNA-targeted small molecule to treat myotonic dystrophy type 1 (DM1) — — Michael Gilman retires from role of CEO following [...]
New PerfectServe Research: 85% of Healthcare Leaders Want to Switch Their Contact Center Vendors, But Most Feel Trapped
25/06/2026
Survey of 105 IT and operational leaders reveals tech fragmentation that harms patient experience and complicates operators’ working environment MIAMI, June 25, 2026 (GLOBE NEWSWIRE) -- PerfectServe ® , a leading [...]
Atalan Launches Nurse Retention Platform Designed to Identify Risk Up to 12 Months in Advance
25/06/2026
Built specifically for nursing, the platform extends Atalan's proven Clinician Retention Intelligence platform to increase retention in healthcare's largest clinical workforce PHILADELPHIA, June 25, 2026 (GLOBE NEWSWIRE [...]
Quantum BioPharma Ltd. (NASDAQ: QNTM) Advancing Innovative, First-in-Class, Patented MS Therapy
25/06/2026
NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the [...]
BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT™
25/06/2026
Agreement supports potential commercial readiness for Bria-IMT using Uneedle’s proprietary microneedle technology for intradermal administration Technology is currently used in BriaCell’s pivotal Phase 3 study and is [...]
Atea Pharmaceuticals Completes Patient Enrollment in Phase 3 C-FORWARD Trial Evaluating Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus
25/06/2026
Topline Phase 3 Results from C-FORWARD Expected Around Year-End 2026 More Than 880 HCV Treatment-Naïve Patients Enrolled Across 17 Countries Outside North America C-FORWARD and C-BEYOND Represent the First Global Phase [...]
Helus Pharma™ Announces Closing of US$50 Million Underwritten Offering
25/06/2026
NEW YORK and TORONTO, June 25, 2026 (GLOBE NEWSWIRE) -- Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP) (the “ Company ” or “ Helus Pharma ”), a clinical stage pharmaceutical company committed to helping minds heal by [...]
Aeroflow Health Acquires Canopie to Close the Maternal Care Gap for Millions of New Mothers
25/06/2026
ASHEVILLE, N.C., June 25, 2026 (GLOBE NEWSWIRE) -- In the ongoing development of its comprehensive maternal health platform, Aeroflow Health , a technology-enabled healthcare company serving millions of patients [...]
TRUE-See Selected to Participate in Microsoft for Start-Ups Azure AI Program to Accelerate Innovation and Growth
25/06/2026
Includes $350,000 in non-dilutive Microsoft Azure AI credits for TRUE-See’s R&D that is incorporating AI to increase the utility and diagnostic accuracy of medical photography TRUE-See’s unique patented technology [...]
Canadian Red Cross and Walmart Canada launch annual giving campaign
25/06/2026
Funds raised support disaster relief in communities across Canada OTTAWA, June 25, 2026 (GLOBE NEWSWIRE) -- As Canadians face an active start to the wildfire season and communities continue to recover from recent floods [...]
Lycia Therapeutics Raises $75 Million in Oversubscribed Financing and Strengthens Leadership Team with Appointment of Chief Financial Officer and General Counsel
25/06/2026
Financing co-led by Janus Henderson Investors and Balyasny Asset Management, with participation from Adage Capital Management, HBM Healthcare Investments, OrbiMed and continued support from existing investors Proceeds [...]
Herantis appoints experienced drug development expert Dr Juha Savola as Chief Medical Officer
25/06/2026
Brings more than 25 years of global drug development, regulatory and strategic leadership experience successfully guiding innovative therapies from clinical development through regulatory approval and commercialization [...]
BrewDog Inverurie Reopens with New Community Champions Model
25/06/2026
Opening set for Saturday 27 th June, featuring live music, entertainment and a sample pint on the house for the first 100 guests 1 New Community Champions model will support local initiatives, events, fundraising, [...]
Young workers willing to make career trade-offs for jobs with pensions: new research from HOOPP and Abacus Data
25/06/2026
TORONTO, June 25, 2026 (GLOBE NEWSWIRE) -- In an economy where young people feel increasing uncertainty about housing, saving money and the cost of living, nearly two-thirds of Canadians under the age of 35 say they [...]
Oblenio Bio Closes $62 Million Series B to Advance Tri-specific T-Cell Engager LBL-051 for Autoimmune Diseases into Clinical Development
25/06/2026
-- Round led by Pfizer Ventures, with participation from Deep Track Capital, GV, and founding investor, Aditum Bio -- --LBL-051’s ability to reset the immune system is supported by recent preclinical data presented at [...]
ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform
25/06/2026
Data from ongoing Phase 1 study of AX-0810 in healthy volunteers demonstrated dose-dependent target engagement on all key biomarkers in the evaluable 3 mg/kg and 6 mg/kg cohorts AX-0810 demonstrated up to 8-fold change [...]
AnaCardio´s Phase 1b/2a GOAL-HF1 study in patients with Heart Failure and Reduced Ejection Fraction (HFrEF) published in The Lancet
25/06/2026
Favourable safety profile in marked contrast to traditional inotropic therapeutics AC01 showed rapid and sustained numerical improvements in cardiac output, structure and function STOCKHOLM, Sweden, June 25, 2026 – [...]
Un nouveau projet de l’ACE pour soutenir les ergothérapeutes diplômés à l’étranger au Canada
25/06/2026
OTTAWA, Ontario, 25 juin 2026 (GLOBE NEWSWIRE) -- Un nouvel effort national est en cours afin de mieux soutenir les ergothérapeutes formés à l’étranger (EFE) dans l'avancement de leur carrière au Canada. L’Association [...]

Pages